https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-020-01401-4 https://www.ncbi.nlm.nih.gov/pubmed/32532258?dopt=Abstract CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial. Related Articles CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial. Respir Res. 2020 Jun 12;21(1):149 Authors: Lazaar AL, Miller BE, Donald AC, Keeley T, Ambery C, Russell […]
